Manuel Macı́as

1.8k total citations
13 papers, 1.5k citations indexed

About

Manuel Macı́as is a scholar working on Endocrine and Autonomic Systems, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Manuel Macı́as has authored 13 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrine and Autonomic Systems, 6 papers in Cardiology and Cardiovascular Medicine and 3 papers in Molecular Biology. Recurrent topics in Manuel Macı́as's work include Circadian rhythm and melatonin (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Acute Myocardial Infarction Research (5 papers). Manuel Macı́as is often cited by papers focused on Circadian rhythm and melatonin (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Acute Myocardial Infarction Research (5 papers). Manuel Macı́as collaborates with scholars based in Spain, Brazil and United Kingdom. Manuel Macı́as's co-authors include Darío Acuña‐Castroviejo, Germaine Escames, Josefa León, Miguel Martı́n, Huda Khaldy, Russel J. Reiter, Francisco Vives, David Pozo, Elena Crespo and Juan M. Guerrero and has published in prestigious journals such as PLoS ONE, The FASEB Journal and European Journal of Biochemistry.

In The Last Decade

Manuel Macı́as

13 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Macı́as Spain 9 957 461 410 189 187 13 1.5k
Huda Khaldy Spain 15 968 1.0× 474 1.0× 384 0.9× 197 1.0× 280 1.5× 18 1.6k
Silvia López‐Burillo United States 15 1.3k 1.3× 535 1.2× 421 1.0× 147 0.8× 180 1.0× 19 2.1k
Marta I. Pablos Spain 17 1.5k 1.5× 435 0.9× 492 1.2× 119 0.6× 267 1.4× 28 2.1k
Yuji Okatani Japan 26 1.0k 1.1× 357 0.8× 453 1.1× 90 0.5× 157 0.8× 75 2.2k
Jaime Eugenı́n Chile 19 522 0.5× 479 1.0× 551 1.3× 166 0.9× 240 1.3× 51 1.9k
Russel J. Reiter United States 8 750 0.8× 256 0.6× 323 0.8× 63 0.3× 150 0.8× 9 1.1k
Mamdouh R. El‐Sawi Egypt 8 623 0.7× 226 0.5× 216 0.5× 71 0.4× 93 0.5× 18 1.2k
R.J. Reiter United States 16 762 0.8× 220 0.5× 265 0.6× 67 0.4× 158 0.8× 26 1.3k
Peter M. Liebmann Austria 18 528 0.6× 223 0.5× 252 0.6× 88 0.5× 157 0.8× 38 1.5k

Countries citing papers authored by Manuel Macı́as

Since Specialization
Citations

This map shows the geographic impact of Manuel Macı́as's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Macı́as with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Macı́as more than expected).

Fields of papers citing papers by Manuel Macı́as

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Macı́as. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Macı́as. The network helps show where Manuel Macı́as may publish in the future.

Co-authorship network of co-authors of Manuel Macı́as

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Macı́as. A scholar is included among the top collaborators of Manuel Macı́as based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Macı́as. Manuel Macı́as is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ruiz-Nodar, Juan M., María Asunción Esteve‐Pastor, Esteban Orenes‐Piñero, et al.. (2022). Clinical implications of diabetes mellitus in patients with acute coronary syndrome: Prognostic role and use of new P2Y12 receptor inhibitors. Diabetes Research and Clinical Practice. 184. 109215–109215. 1 indexed citations
2.
Ruiz-Nodar, Juan M., María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, et al.. (2020). One‐year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry. British Journal of Clinical Pharmacology. 86(6). 1052–1061. 8 indexed citations
3.
Marı́n, Francisco, José Miguel Rivera‐Caravaca, María Asunción Esteve‐Pastor, et al.. (2019). Switching of Oral P2Y12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis. Clinical Drug Investigation. 39(3). 275–283. 2 indexed citations
4.
Marı́n, Francisco, José Miguel Rivera‐Caravaca, María Asunción Esteve‐Pastor, et al.. (2018). Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines. PLoS ONE. 13(11). e0208069–e0208069. 3 indexed citations
5.
Orenes‐Piñero, Esteban, Juan M. Ruiz-Nodar, María Asunción Esteve‐Pastor, et al.. (2017). Therapeutic management and one-year outcomes in elderly patients with acute coronary syndrome. Oncotarget. 8(46). 80182–80191. 10 indexed citations
6.
Esteve‐Pastor, María Asunción, Manuel Macı́as, Francisco Sogorb, et al.. (2016). Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?. Circulation Journal. 80(10). 2102–2108. 16 indexed citations
7.
Macı́as, Manuel, et al.. (2003). Calreticulin–melatonin. European Journal of Biochemistry. 270(5). 832–840. 81 indexed citations
8.
Escames, Germaine, Josefa León, Manuel Macı́as, Huda Khaldy, & Darío Acuña‐Castroviejo. (2003). Melatonin counteracts lipopolysaccharide‐induced expression and activity of mitochondrial nitric oxide synthase in rats. The FASEB Journal. 17(8). 1–22. 171 indexed citations
9.
Martı́n, Miguel, Manuel Macı́as, Josefa León, et al.. (2002). Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. The International Journal of Biochemistry & Cell Biology. 34(4). 348–357. 222 indexed citations
10.
Acuña‐Castroviejo, Darío, Miguel Martı́n, Manuel Macı́as, et al.. (2001). Melatonin, mitochondria, and cellular bioenergetics. Journal of Pineal Research. 30(2). 65–74. 349 indexed citations
11.
León, Josefa, Manuel Macı́as, Germaine Escames, et al.. (2000). Structure-Related Inhibition of Calmodulin-Dependent Neuronal Nitric-Oxide Synthase Activity by Melatonin and Synthetic Kynurenines. Molecular Pharmacology. 58(5). 967–975. 113 indexed citations
12.
Martı́n, Miguel, Manuel Macı́as, Germaine Escames, Josefa León, & Darío Acuña‐Castroviejo. (2000). Melatonin but not vitamins C and E maintains glutathione homeostasis in t‐butyl hydroperoxide‐induced mitochondrial oxidative stress. The FASEB Journal. 14(12). 1677–1679. 310 indexed citations
13.
Crespo, Elena, Manuel Macı́as, David Pozo, et al.. (1999). Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide‐induced multiple organ dysfunction syndrome in rats. The FASEB Journal. 13(12). 1537–1546. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026